Social media

Drop by booth \#69 at #OCTNewEngland2025, 15– 16 October. Meet the ICON experts to explore new solutions to common issues within clinical trials. Learn how we can simplify processes to help you meet critical milestones, ...

Despite increased female participation, most Clinical Outcome Assessments (COAs) are still designed around male biology. A recent analysis found that less than 10% of COAs were developed with female-specific populations....

We are proud to share that our colleagues in Sofia took part in the Race for the Cure® on 28 September. Race for the Cure is Europe’s largest sporting event for women’s health, bringing together communities to support b...

Big news in clinical research! The updated ICH GCP E6(R3) guideline is here and it’s changing how trials are designed and run. Our article in PharmaTimes explains why a detailed impact assessment is the first step to sta...

ICH GCP E6(R3) is here. Are you ready? The new guideline introduces sweeping changes to clinical trial operations. In the latest issue of PharmaTimes, ICON’s own Joanne Perry explores why a comprehensive impact assessm...

Biomarkers are redefining clinical trial success in neurodegenerative diseases. Join us for a focused webinar on how imaging, wet, genetic, and digital biomarkers are improving trial accuracy, patient selection, and end...

Join leading experts in #neuroscience and clinical development as they discuss how #biomarkers are transforming trials in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases. This session will cover: - Inte...

We’re looking forward to participating in and hosting C-Path's annual eCOA Consortium EU meeting on October 8–9 at ICON’s Dublin office. This meeting brings together leading eCOA experts to address key industry challen...

We’re looking forward to participating in and hosting C-Path's annual eCOA Consortium EU meeting on October 8–9 at ICON’s Dublin office. This meeting brings together leading eCOA experts to address key industry challen...

LabView360 is ICON’s new digital requisitioning application that streamlines end-to-end sample management—eliminating paper requisition forms, reducing errors, and saving valuable time for sites and sponsors. With digi...

LabView360 is ICON’s new digital requisitioning application that streamlines end-to-end sample management—eliminating paper requisition forms, reducing errors, and saving valuable time for sites and sponsors. With digi...

#RAPSConvergence 2025 is less than a week away! Join ICON in Pittsburgh, 7 - 9 October, for the largest annual event dedicated to regulatory affairs. At booth 409, our team will showcase how we can facilitate end-to-end...